Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-1005 in Adults Receiving a Cochlear Implant
NCT06340633Phase 2Recruiting
- Sponsor
- Sound Pharmaceuticals
- Start
- Dec 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ebselen in Cochlear trauma, hearing loss, sponsored by Sound Pharmaceuticals. Planned start Dec 2026; status: recruiting.
02
Drugs
ebselen
03
Conditions
Cochlear traumahearing loss
Beyond the preview
Go deeper on NCT06340633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06340633.